BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 12391525)

  • 1. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
    Dünser M; Wenzel V; Mayr AJ; Hasibeder WR
    Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.
    Dünser MW; Mayr AJ; Ulmer H; Knotzer H; Sumann G; Pajk W; Friesenecker B; Hasibeder WR
    Circulation; 2003 May; 107(18):2313-9. PubMed ID: 12732600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of vasodilatory shock: defining the role of arginine vasopressin.
    Dunser MW; Wenzel V; Mayr AJ; Hasibeder WR
    Drugs; 2003; 63(3):237-56. PubMed ID: 12534330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac performance during vasopressin infusion in postcardiotomy shock.
    Dünser MW; Mayr AJ; Stallinger A; Ulmer H; Ritsch N; Knotzer H; Pajk W; Mutz NJ; Hasibeder WR
    Intensive Care Med; 2002 Jun; 28(6):746-51. PubMed ID: 12107681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dear vasopressin, where is your place in septic shock?
    Duenser MW; Hasibeder WR
    Crit Care; 2005 Apr; 9(2):134-5. PubMed ID: 15774061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin in sepsis and septic shock.
    Kampmeier TG; Rehberg S; Westphal M; Lange M
    Minerva Anestesiol; 2010 Oct; 76(10):844-50. PubMed ID: 20935620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arginine-vasopressin in septic and vasodilatorial shock].
    Dünser MW; Hasibeder WR; Wenzel V; Meier-Hellmann A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Nov; 41(11):716-9. PubMed ID: 17151983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin in catecholamine-refractory shock in children.
    Meyer S; Gortner L; McGuire W; Baghai A; Gottschling S
    Anaesthesia; 2008 Mar; 63(3):228-34. PubMed ID: 18081903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors.
    Dünser MW; Mayr AJ; Tür A; Pajk W; Barbara F; Knotzer H; Ulmer H; Hasibeder WR
    Crit Care Med; 2003 May; 31(5):1394-8. PubMed ID: 12771608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine vasopressin in vasodilatory shock.
    Fuchs FD; Filho JW
    Circulation; 2003 Nov; 108(19):e141; author reply e141. PubMed ID: 14610004
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis.
    Dünser MW; Mayr AJ; Ulmer H; Ritsch N; Knotzer H; Pajk W; Luckner G; Mutz NJ; Hasibeder WR
    Anesth Analg; 2001 Jul; 93(1):7-13. PubMed ID: 11429329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.
    Argenziano M; Chen JM; Choudhri AF; Cullinane S; Garfein E; Weinberg AD; Smith CR; Rose EA; Landry DW; Oz MC
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):973-80. PubMed ID: 9832689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
    Bauer SR; Lam SW; Cha SS; Oyen LJ
    J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine vasopressin in advanced vasodilatory shock.
    De Backer D; Creteur J; Vincent JL
    Circulation; 2003 Nov; 108(19):e142; author reply e142. PubMed ID: 14610005
    [No Abstract]   [Full Text] [Related]  

  • 15. Arginine vasopressin for the treatment of septic shock in adults.
    Bauer SR; Lam SW
    Pharmacotherapy; 2010 Oct; 30(10):1057-71. PubMed ID: 20874043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD; Jung R; Fish DN; MacLaren R
    Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose vasopressin is not superior to norepinephrine in septic shock.
    Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
    Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous arginine vasopressin infusion in refractory vasodilatory shock: a clinical study.
    Agrawal A; Singh VK; Varma A; Sharma R
    Indian J Pediatr; 2012 Apr; 79(4):488-93. PubMed ID: 21922300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of exogenous arginine vasopressin in the management of catecholamine-refractory septic shock.
    Lee CS
    Crit Care Nurse; 2006 Dec; 26(6):17-23. PubMed ID: 17123948
    [No Abstract]   [Full Text] [Related]  

  • 20. Arginine vasopressin as a rescue vasopressor agent in the operating room.
    Jochberger S; Wenzel V; Dünser MW
    Curr Opin Anaesthesiol; 2005 Aug; 18(4):396-404. PubMed ID: 16534265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.